Fatty Liver and GLP-1: The Hidden Benefit
Hepatic steatosis affects 1 in 3 Europeans. GLP-1 peptides reduce liver fat by up to 82%. Discover how TRIPLE-G acts on the liver.
Deep dives into molecular biology and the future of peptide research.
Sarcobesity means losing muscle instead of fat. Learn how to avoid it with protein, resistance training, and the triple agonist TRIPLE-G.
GLP-1 peptide rebound: real data on weight regain, why it happens and how to prevent it. Evidence-based exit strategy to maintain your results.
Why can't I lose weight? It's not your fault. Neuroscience explains what happens in the brain when you diet and why willpower isn't enough.
Food Noise is the constant internal dialogue pushing you to eat. It's not real hunger. Discover what it is and how science stops it.
GLP-1 peptides do more than help you lose weight. Heart, liver, blood sugar, inflammation, joints, brain: clinical trial data on 10+ extra benefits.
Metabolism isn't fast or slow. It's a 3-switch system. Discover how it really works, why it stalls, and what science says to reactivate it.
Weight loss peptide news 2026: retatrutide phase 3, new molecules, global GLP-1 trend. Updates from research and the European market.
95% of diets fail within 5 years. Not from lack of willpower — from biology. Discover the 7 real reasons and what actually works according to science.
Next-generation molecules in development for obesity: from quadruple agonism to amylin, from gene therapy to oral peptides. What comes after retatrutide.
HPLC chromatography applied to peptides: how it works, how to read results, why purity matters and the difference between 95-99%+.